Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Debt to Equity (2016 - 2017)

Historic Debt to Equity for Lisata Therapeutics (LSTA) over the last 8 years, with Q2 2017 value amounting to $0.01.

  • Lisata Therapeutics' Debt to Equity fell 9944.39% to $0.01 in Q2 2017 from the same period last year, while for Jun 2017 it was $0.01, marking a year-over-year decrease of 9944.39%. This contributed to the annual value of $1.16 for FY2016, which is 7961.72% up from last year.
  • As of Q2 2017, Lisata Therapeutics' Debt to Equity stood at $0.01, which was down 9944.39% from -$3.87 recorded in Q1 2017.
  • Lisata Therapeutics' 5-year Debt to Equity high stood at $1.56 for Q2 2016, and its period low was -$3.87 during Q1 2017.
  • Its 5-year average for Debt to Equity is $0.14, with a median of $0.23 in 2014.
  • In the last 5 years, Lisata Therapeutics' Debt to Equity surged by 205255.32% in 2014 and then crashed by 68927.26% in 2017.
  • Lisata Therapeutics' Debt to Equity (Quarter) stood at $0.01 in 2013, then soared by 2052.55% to $0.26 in 2014, then skyrocketed by 149.42% to $0.64 in 2015, then surged by 79.62% to $1.16 in 2016, then crashed by 99.25% to $0.01 in 2017.
  • Its Debt to Equity was $0.01 in Q2 2017, compared to -$3.87 in Q1 2017 and $1.16 in Q4 2016.